Literature DB >> 24054837

Immune mechanisms in type 1 diabetes.

Maja Wållberg1, Anne Cooke.   

Abstract

There are three prerequisites for development of the autoimmune disease type 1 diabetes (T1D). First, β cell-reactive T cells need to be activated; second, the response needs to be proinflammatory; and finally, immune regulation of autoreactive responses must fail. Here, we describe our current understanding of the cell types and immune mechanisms involved in each of these steps leading to T1D. Novel findings regarding β cell involvement in its own destruction, the importance of the microbiota for instruction of the immune system, and recent data from studies in T1D patients are discussed. In addition, we summarise therapeutic approaches to T1D, and how these relate to the immune mechanisms involved in disease development.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  autoimmunity; environment; genetics; type 1 diabetes

Mesh:

Year:  2013        PMID: 24054837     DOI: 10.1016/j.it.2013.08.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  55 in total

Review 1.  Role of viruses and bacteria-virus interactions in autoimmunity.

Authors:  Ashley L Steed; Thaddeus S Stappenbeck
Journal:  Curr Opin Immunol       Date:  2014-10-27       Impact factor: 7.486

Review 2.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

3.  Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes.

Authors:  S Alice Long; Jerill Thorpe; Hannah A DeBerg; Vivian Gersuk; James Eddy; Kristina M Harris; Mario Ehlers; Kevan C Herold; Gerald T Nepom; Peter S Linsley
Journal:  Sci Immunol       Date:  2016-11-18

Review 4.  Islet inflammation in type 2 diabetes and physiology.

Authors:  Kosei Eguchi; Ryozo Nagai
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 5.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

6.  Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice.

Authors:  Susan J Burke; Heidi M Batdorf; Adrianna E Eder; Michael D Karlstad; David H Burk; Robert C Noland; Z Elizabeth Floyd; J Jason Collier
Journal:  Am J Pathol       Date:  2017-01-04       Impact factor: 4.307

7.  Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response.

Authors:  Xiao-Qun Han; Zuo-Jiong Gong; San-Qing Xu; Xun Li; Li-Kun Wang; Shi-Min Wu; Jian-Hong Wu; Hua-Fen Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

8.  Cutting Edge: Loss of T Cell RIAM Precludes Conjugate Formation with APC and Prevents Immune-Mediated Diabetes.

Authors:  Frederic Lagarrigue; Frank B Gertler; Mark H Ginsberg; Joseph M Cantor
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

Review 9.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

10.  Liraglutide Enhances the Efficacy of Human Mesenchymal Stem Cells in Preserving Islet β-cell Function in Severe Non-obese Diabetic Mice.

Authors:  Li-Rong Li; Xiao-Lei Jia; Hui Hui; Jie Zhang; Ying Liu; Wei-Juan Cui; Qian-Yue Xu; Da-Long Zhu
Journal:  Mol Med       Date:  2016-11-17       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.